1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Industry: Forecasts to 2024

  • October 2016
  • 183 pages
  • ID: 4415260
In this report:
The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information.
Quantitative analysis includes market share held by companies in 2015, market size, and forecast for the global human vaccines market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Italy, Spain, Japan, China, Brazil, Mexico, South Africa and GCC countries.

Summary

Table of Contents

Human Vaccines Market: Scope and Methodology

This business report offers detailed region wise and country wise analysis of the human vaccines market. Stakeholders of this report contain manufacturers of human vaccines products, raw material suppliers, vaccine processing companies, and additional players planning to enter the industry.

The market research offers qualitative and quantitative analysis of the overall human vaccines market. Qualitative analysis comprises market forces, forecasts, product overview, and country-level market information. Quantitative analysis includes segment market share held by firms in 2015, market value, and estimate for the overall human vaccines market in main countries globally including the U.S., Canada (CA), Germany (DE), France (FR), United Kingdom, Italy (IT), Spain (ES), Japan (JP), China (CN), Brazil (BR), Mexico (MX), South Africa (ZA) and GCC countries. Market income is specified in terms of US$ Mn from 2014 to 2024 along with the CAGR from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report offers a snapshot of the human vaccines with info on leading segments, country wise market information with respect to the market size, rate of growth, and growth factors.

The market survey part comprises impact factors including drivers, market restraints, and alternatives for the overall human vaccines market. These aspects would aid the stakeholders in establishing a strong foothold in the overall human vaccines market. Moreover, the market survey part comprises main industry events, product overview, Analysis of market appeal and emerging trend in the human vaccines. The Analysis of market appeal offers a graphical view comparing the growth and market forces in different segments and country wise to identify the most engaging market. Market share review is also provided in the ambitious landscape section of the report for the year 2015 in terms of value.

Human Vaccines Market: Segmentation

The human vaccines market has been split as vaccine type, products, age group, distribution channel and territory. Established on vaccine type, the sector has been divided into conjugate, recombinant, inactivated, combination, attenuated, and others. Likewise, on basis of product the market has been categorized into pneumococcal, influenza, hepatitis, HPV, meningococcal, rotavirus, measles and mumps, typhoid, combination and others. By age group the market is classified into pediatrics, adolescent, adult and geriatrics. Hospital pharmacies, drugstores and others are included into the industry by distribution channel

Geographically, the human vaccines market has been classified into North America continent, Europe (EU), Asia Pacific (APAC), Latin America area, and Middle East (ME) & African continent. Furthermore, analysis for the main countries comprising U.S. Canada, Germany (DE), U.K., France (FR), Italy (IT), Spain (ES), Japan (JP), China (CN), Brazil (BR), Mexico (MX), and South Africa (ZA) have also been provided in the industry report. A exhaustive qualitative analysis of the factors responsible for driving and restraining the growth of the human vaccines market in several regions has been provided in this part. This industry report also comprises different ups and downs about particular country or area that has impacted the global market globally.

Human Vaccines Market: Opposing landscape

The study offers an exhaustive outline/blueprint of the human vaccines market globally that will assist additional companies in establishing their presence and industry actors in expanding their market share in the sector. The analysis closes with the company profile section which comprises company overview, financial review, SWOT study, product portfolio, strategic management and recent evolutions for market actors. The main players that are profiled in the market research contain Top actors operating in the overall human vaccines market contain AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer, Incorporated, Sanofi and Johnson & Johnson among others.

The overall human vaccines market is broken down into the following categories:

Overall human Vaccines Market, by Vaccine Type

Overall Human Vaccines Market, by Product

Overall Human Vaccines Market, by Age Group

Overall Human Vaccines Market, by Distribution Channel

Overall Human Vaccines Market, by Geography

North America (NA)

USA

Canada (CA)

Europe (EU)

Germany (DE)

France (FR)

United Kingdom (UK)

Italy (IT)

Spain (ES)

Rest of europe (EU)

Asia-Pac

Japan (JP)

China (CN)

Association of southeast asian nations (asean)

Rest of Asia-Pac

Latin America

Brazil (BR)

Mexico (MX)

Rest of LATAM

African region & Middle East

Gulf cooperation council (gcc)

South africa (SA)

Rest of middle east and African regions (MEA)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Seasonal Influenza: Competitive Landscape to 2026

Seasonal Influenza: Competitive Landscape to 2026

  • $ 3495
  • November 2018

Seasonal Influenza: Competitive Landscape to 2026SummaryInfluenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, ...

Rabies - Pipeline Review, H2 2018

Rabies - Pipeline Review, H2 2018

  • $ 2000
  • October 2018

Rabies - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Pipeline Review, H2 2018, provides an overview of the Rabies (Infectious ...

Hepatitis A - Pipeline Review, H2 2018

Hepatitis A - Pipeline Review, H2 2018

  • $ 2000
  • October 2018

Hepatitis A - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Pipeline Review, H2 2018, provides an overview of the Hepatitis ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on